IRCT20200325046859N1已完成2 期
Evaluation of the efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 (Before intubation phase) who have not responded to treatment with the standard three-drug protocol (hydroxychloroquine / chloroquine + lupinavir / ritonavir + ribavirin)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Informed consent for inclusion in the study
- •Age range within 18 to 25 years old
- •Definitive diagnosis with COVID-19
- •Having one of the factors of decrease in consciousness level, RR=24? BP<90/60, Multi-lobe lung problem and hypoxemia
- •Certainty about non responsiveness of standard three-drug protocol of hydroxychloroquine / chloroquine + lupinavir / ritonavir + ribavirin
排除标准
- •Sensitivity to IVIg
- •Having a comorbidities such as heart diseases that IVIg cannot be used
研究者
相似试验
招募中
3 期
Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine stormCondition 1: COVID-19. Condition 2: Coronavirus (COVID-19)-induced pneumonia.U07.1: COVID-19, virus identifiedPneumonia due to SARS-associated coronavirusU07.1J12.81IRCT20200317046797N3Tabriz University of Medical Sciences100
已完成
不适用
Comparison of the effect of Intravenous immunoglobulin and rhophylacIdiopathic thrombocytopenic purpura.Idiopathic thrombocytopenic purpura (Evans syndrome)IRCT2012102811289N1Arak University of Medical Sciences, Vice Chancellor for Research60
招募中
2 期
Evaluation of intravenous immunoglobulin versus corticosteroid in immune thrombocytopenic purpuraImmune thrombocytopenic purpuraIRCT20221206056735N1Shahid Beheshti University of Medical Sciences100
已完成
不适用
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL)Acute lymphoblastic leukemiaJPRN-UMIN000015179agoya University Graduate School of Medicine30
招募中
不适用
Prospective study on the efficacy of intravenous glucocorticoid therapy in Japanese patients with Graves' ophthalmopathy.JPRN-UMIN000021482Kurume University Medical Center300